Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial.
J Antimicrob Chemother
; 73(7): 1965-1971, 2018 07 01.
Article
in En
| MEDLINE
| ID: mdl-29608685
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
HIV Infections
/
Lamivudine
/
Anti-HIV Agents
/
Viral Load
/
Heterocyclic Compounds, 3-Ring
Type of study:
Clinical_trials
/
Guideline
Limits:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
J Antimicrob Chemother
Year:
2018
Type:
Article
Affiliation country:
Spain